教育经历 1990/09-1994/06：中国科学院应用生态研究所 微生物制药学专业 博士 1986/09-1990/06：山东大学 微生物学专业 学士

工作经历 2016-至今：华东理工大学 教授 2006-2016 ： 中国科学院微生物研究所 研究员/博导/ 2004.10-2006.02： 中国科学院广州生物医药与健康研究院 研究员/博导/海洋微生物天然产物药物研究室主任 2004.01-2006.02： 美国SynerZ制药公司 董事长 2001.10-2003.12： 美国CETEK制药公司 微生物学部主任 1998.12-2001.10： 美国Microbia生物制药公司 高级科学家 1998.07-1998.12： 美国爱默瑞大学 助理教授 1994.12-1998.06： 美国爱默瑞大学 微生物药理学 博士后研究

Wupeng Yan, Heng Song, Fuhang Song, Yisong Guo, Cheng-Hsuan Wu, Ampon Sae Her, Yi Pu, Shu Wang, Nathchar Naowarojna, Andrew Weitz, Michael P. Hendrich, Catherine E. Costello, Zhang L*, Pinghua Liu*, and Yan Jessie Zhang*. 2015. Endoperoxide Formation Catalyzed by FtmOx1, an α-Ketoglutarate-dependent Mononuclear Non-heme Iron Enzyme. Nature, 527, 539–543.

Bai C, Zhang Y, Zhao X, Hu Y, Xiang S, Miao J, Lou C*, Zhang L*. 2015. Exploiting a precise design of universal synthetic modular regulatory elements to unlock the microbial natural products in Streptomyces. Proc Natl Acad Sci U S A. 112 (39), 12181-6.

Wang Qian, Song Fuhang, Xiao Xue, Huang Pei, Li Li, Aaron Monte, Wael M. Abdel-Mageed, Wang Jian, Guo Hui, He Wenni, Xie Feng, Dai Huanqin, Liu Miaomiao, Chen Caixia, Xu Hao, Liu Mei, Andrew M. Piggott, Liu Xueting*, Robert J. Capon*, Zhang Lixin*. Abyssomicins from the South China Sea deep-sea sediment Verrucosispora sp.: Natural thioether Michael addition adducts as antitubercular prodrugs. Angew. Chem.-Int. Edit. 2013, 52, 1231-1234.

Zhuo Ying, Zhang Wenquan, Chen Difei, Gao Hong, Tao Jun, Liu Mei, Gou Zhongxuan, Zhou Xianlong, Ye Bangce, Zhang Qing, Zhang Siliang, Zhang Lixin*. Reversebiological engineering of hrdB to enhance the production of avermectins in an industrial strain of Streptomyces avermitilis, Proc. Natl. Acad. Sci. U S A, 2010,107(25), 11250-11254.

Ashforth Elizabeth Jane, Fu Chengzhang, Liu Xiangyang, Dai Huanqin, Song Fuhang, Guo Hui, Zhang Lixin*. Bioprospecting for antituberculosis leads from microbial metabolites. Nat Prod Rep. 2010, 27, 1709-1719.

Zhang Lixin*, Yan Kezhi, Zhang Yu et al. High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections. Proc Natl Acad Sci U S A, 2007, 104(11), 4606-4611."